Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Risk factors

Topic: Amyloid, tau and blood-test diagnosis

INTRODUCTIONSleep-dependent memory consolidation is impaired early in Alzheimers disease (AD). Closed-loop auditory stimulation (CLAS) of sleep slow oscillations enhances memory consolidation in healthy individuals, but its efficacy in AD remains unknown. METHODSWe conducted a randomized, double-blind, placebo-controlled crossover trial in 37 patients with biomarker-confirmed early symptomatic AD and an amnestic clinical phenotype. We assessed the effect of one night of CLAS, compared with one night of sham stimulation, on declarative memory retention, sleep electrophysiology, and sleep architecture. RESULTSCLAS significantly improved overnight word-pair consolidation (Cohens dz = 0.42, p = 0.04), enhanced stimulation-evoked slow-wave and fast spindle activity, and preserved sleep architecture and subjective sleep quality. DISCUSSIONThis study provides the first demonstration that CLAS modulates sleep electrophysiology and improves overnight memory consolidation in patients with biomarker-confirmed AD. Further studies need to address the sustainability of such effects with multi-night interventions for a clinically meaningful intervention.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Lopez-Larraz, E., Oriol, D., Fierro, G., Jubera-Garcia, E., Klinzing, J. G., Sierra-Torralba, M., et al. (2026). One night of closed-loop auditory stimulation during sleep enhances memory consolidation in patients with Alzheimer's Disease. medRxiv (preprint). https://doi.org/10.64898/2026.09.14.26360893

Vancouver

Lopez-Larraz E, Oriol D, Fierro G, Jubera-Garcia E, Klinzing JG, Sierra-Torralba M, et al. One night of closed-loop auditory stimulation during sleep enhances memory consolidation in patients with Alzheimer's Disease. medRxiv (preprint). 2026. doi:10.64898/2026.09.14.26360893.

BibTeX

@article{lopezlarraz2026-5e962d7a,
  author  = {Lopez-Larraz, E. and Oriol, D. and Fierro, G. and Jubera-Garcia, E. and Klinzing, J. G. and Sierra-Torralba, M. and Horna-Prat, E. and Escolano and others},
  title   = {{One night of closed-loop auditory stimulation during sleep enhances memory consolidation in patients with Alzheimer's Disease}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.09.14.26360893},
  url     = {https://doi.org/10.64898/2026.09.14.26360893}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

In a small randomized trial of 37 patients with early Alzheimer's disease, one night of closed-loop auditory stimulation during sleep improved overnight memory consolidation compared with sham stimulation. The authors note that further studies are needed to see whether these effects last with multiple nights of treatment.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 5 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 3 of 3; Multi-centre collaboration 3 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 31 of the 94 points it could be judged on, which is 33 of 100. Raw total 33 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 33 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 33 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, effect reported and randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 31 of the 94 points we could judge it on, which is 33 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 1 / 4 37 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Javier Mínguez: h-index 39 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multi-centre collaboration 3 / 3 OpenAlex lists 12 institution(s) in 3 countries
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 31 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 31 of the 94 points we could judge it on is 33 out of 100.
Total 33 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Related studies in Risk factors

Also tagged “double-blind”

783 studies in the library carry the topic tag “double-blind”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.

Similar studies

More on Risk factors

See all studies in Risk factors →